Combination of the sodium-glucose cotransporter-2 inhibitor empagliflozin with orlistat or sibutramine further improves the body-weight reduction and glucose homeostasis of obese rats fed a cafeteria diet (Q33857698)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combination of the sodium-glucose cotransporter-2 inhibitor empagliflozin with orlistat or sibutramine further improves the body-weight reduction and glucose homeostasis of obese rats fed a cafeteria diet |
scientific article |
Statements
1 reference
Combination of the sodium-glucose cotransporter-2 inhibitor empagliflozin with orlistat or sibutramine further improves the body-weight reduction and glucose homeostasis of obese rats fed a cafeteria diet (English)
1 reference
Steven P Vickers
1 reference
Sharon C Cheetham
1 reference
Katie R Headland
1 reference
Keith Dickinson
1 reference
Rolf Grempler
1 reference
Eric Mayoux
1 reference
Michael Mark
1 reference
Thomas Klein
1 reference
1 July 2014
1 reference
265-275
1 reference
Identifiers
1 reference
1 reference
1 reference